19:31 , Jan 24, 2018 |  BC Innovations  |  Emerging Company Profile

D over L for diabetes

ImmunoMolecular Therapeutics LLC’s small molecule inhibitor of an HLA-DQ8 peptide could treat Type I diabetes without courting the broad-spectrum immunosuppression of other disease-modifying therapies in development. About 60% of Type I diabetes patients carry the HLA-DQ8...
21:28 , Nov 10, 2017 |  BC Week In Review  |  Company News

IM Therapeutics launches with T1D candidate

Autoimmune company ImmunoMolecular Therapeutics LLC (Broomfield, Colo.) emerged from stealth mode with a small molecule candidate that aims to treat Type I diabetes by preventing the initiation of the autoimmune response against insulin-producing beta cells. The...
05:01 , Nov 9, 2017 |  BC Extra  |  Company News

IM Therapeutics emerges from stealth with small molecule for T1D

ImmunoMolecular Therapeutics LLC (Broomfield, Colo.) emerged from stealth mode with a small molecule candidate that aims to treat Type I diabetes by preventing the initiation of the autoimmune response against insulin-producing beta cells. The company was...
08:00 , Mar 6, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes Insulin Mouse studies suggest antibodies that prevent the recognition of specific autoimmunogenic insulin complexes could...
08:00 , Mar 3, 2011 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

This week in techniques Approach Summary Licensing status Publication and contact information Disease models Mouse model of early celiac disease A mouse model of celiac disease could aid...
07:00 , Mar 27, 2008 |  BC Innovations  |  Targets & Mechanisms

Celiac Attack

The only current treatment for celiac disease, a disorder of the small intestine that results from a hypersensitivity to ingested gluten, is lifelong adherence to a gluten-free diet. However, it is difficult to follow such...